Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Hims & Hers Health Inc shares valued at $14,000 were purchased by Chi Michael on Oct 01 ’25. At $56.00 per share, Chi Michael acquired 250 shares.
Also, Okupe Oluyemi sold 85,000 shares, netting a total of over 5,116,924 in proceeds. Following the sale of shares at $60.20 each, the insider now holds 70,232 shares.
Before that, Boughton Soleil had sold 2,637 shares from its account. In a trade valued at $155,029, the Chief Legal Officer traded Hims & Hers Health Inc shares for $58.79 each. Upon closing the transaction, the insider’s holdings decreased to 2,637 shares, worth approximately $9.22 million.
As published in a research note from Needham on June 23, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Buy to a Hold. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in early June. As of April 29, 2025, TD Cowen has decreased its “Buy” rating to a “Hold” for HIMS. Earlier on February 18, 2025, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for HIMS stock which previously was a “an Overweight”.
Analyzing HIMS Stock Performance
On last trading session, Hims & Hers Health Inc [NYSE: HIMS] plunged -0.72% to $56.31. The stock’s lowest price that day was $55.0859, but it reached a high of $57.6063 in the same session. During the last five days, there has been a surge of approximately 5.75%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 216.88%. Shares of the company reached a 52-week high of $72.98 on 02/19/25 and a 52-week low of $23.97 on 04/04/25.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 55.06, which, if violated, would cause prices to drop to 53.81. In the upper region, resistance lies at 57.58. The next price resistance is at 58.85. RSI (Relative Strength Index) is 56.53 on the 14-day chart, showing neutral technical sentiment.
Is Hims & Hers Health Inc subject to short interest?
Stocks of Hims & Hers Health Inc saw a sharp steep in short interest on 2025-09-15 dropping by -3.68 million shares to 66.53 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 70.22 million shares. A decline of -5.54% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.58 of the overall float, the days-to-cover ratio (short ratio) decline to 2.58.
Which companies own the most shares of Hims & Hers Health Inc (HIMS)?
In terms of Hims & Hers Health Inc share price expectations, FactSet research, analysts set an average price target of 45 in the next 12 months, down nearly -20.66% from the previous closing price of $56.72. Analysts anticipate Hims & Hers Health Inc stock to reach 65 by 2025, with the lowest price target being 30. In spite of this, 13 analysts ranked Hims & Hers Health Inc stock as Buy at the end of 2025. On January 10, 2025, Citigroup assigned a price target of “a Sell” to the stock and downgraded coverage with a $25.
